- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
NCT00795769
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01432600
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Mount Sinai School of Medicine, The Tisch Cancer Institute New York, United States
NCT02111954
- Conditions
- Disease Attributes, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland
NCT01427881
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01583543
- Conditions
- Disease Attributes, Ewing's Sarcoma, Neoplasm Metastasis, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
NCT00049504
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +160 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01211938
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +8 more
- Locations
-
- Institut Gustave Roussy Villejuif, France
Completed
Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT01289522
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
- Locations
-
- Cliniques Universitaires Brussels, Belgium
- Clinique Sainte Elisabeth Namur, Belgium
- Clinique universitaire de Mont Godinne UCL Yvoir, Belgium
- Hôpital Saint André Bordeaux, France
NCT01776411
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
- Nagoya Daini Red Cross Hospital Nagoya, Aichi-ken, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Hospital Organization Shikoku Cancer Center Matsuyama, Ehime, Japan